The federal government has approved Reyvow (lasmiditan) tablets for the acute (active but short-term) treatment of migraine with or without aura in adults. Reyvow is not indicated for the preventive treatment of migraine. “Reyvow is a new option for the acute treatment of migraine, a painful condition that affects one in seven Americans,” said Nick… Continue reading FDA Approves New Migraine Remedy
FDA Approves New Migraine Remedy
Notice: Undefined index: width in /var/www/html/wp-includes/media.php on line 1285
Notice: Undefined index: height in /var/www/html/wp-includes/media.php on line 1286